Evaluation and Referral for Developmental Dysplasia of the Hip in Infants.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] 20. Cureus. 2023 Sep 18;15(9):e45503. doi: 10.7759/cureus.45503. eCollection 2023 Sep. An Overview of Developmental Dysplasia of the Hip and Its Management Timing and Approaches. Alhaddad A(1), Gronfula AG(2), Alsharif TH(3), Khawjah AA(3), Alali MY(4), Jawad KM(5). Author information: (1)Orthopedic Surgery, East Jeddah General Hospital, Jeddah, SAU. (2)Orthopaedic Surgery, Royal College of Surgeons in Ireland, Dublin, IRL. (3)Neurosurgery, Royal College of Surgeons in Ireland, Dublin, IRL. (4)Emergency Medicine, Royal College of Surgeons in Ireland, Dublin, IRL. (5)Orthopaedics, East Jeddah General Hospital, Jeddah, SAU. Developmental dysplasia of the hip (DDH), if uncorrected, can result in several chronic abnormalities, including chronic hip pain, degenerative arthritis, and gait abnormalities. The outcome of DDH generally depends on the age of presentation; a worse prognosis is linked to a higher age of presentation. Although treatment continues to be a challenge, recent advancements in the field have improved our understanding of the disease, which has resulted in advancements in DDH surveillance during infancy and the reduction of complications with early intervention. The databases used for this overview include Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Library, MEDLINE, and EMBASE. These databases were used to search for ongoing trials related to the management and diagnosis of DDH. Copyright © 2023, Alhaddad et al. DOI: 10.7759/cureus.45503 PMCID: PMC10585185